Spring BioScience Corporation
6Patents
4Active
6Granted
38Portfolio score
Filing activity: Sep 11, 2002 → Oct 6, 2017
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9885721B2 | PD-L1 antibodies and uses thereof | Physics | 5 | Active |
| US7148332B2 | High affinity monoclonal antibody for recognizing the estrogen receptor (ER) and method for creating the antibody | Emerging Cross-Sectional Technologies | 2 | Expired |
| US7569675B2 | High affinity monoclonal antibody for recognizing the progesterone receptor (PR) and method for creating the antibody | Emerging Cross-Sectional Technologies | 1 | Expired |
| US10501544B2 | Anti-B7-H3 antibodies and diagnostic uses thereof | Physics | 1 | Active |
| US10689445B2 | Anti-PD-L1 antibodies and diagnostic uses thereof | Physics | 1 | Active |
| US10436785B2 | Anti-indoleamine 2,3-dioxygenase 1 antibodies and diagnostic uses thereof | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.